Recap: Clovis Oncology Q2 Earnings

Clovis Oncology CLVS reported its Q2 earnings results on Monday, August 8, 2022 at 06:00 AM.

Here's what investors need to know about the announcement.

Clovis Oncology missed estimated earnings by 21.95%, reporting an EPS of $-0.5 versus an estimate of $-0.41.

Revenue was down $4.68 million from the same period last year.

Last quarter the company missed on EPS by $0.01 which was followed by a 12.5% drop in the share price the next day.

Here's a look at Clovis Oncology's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	-0.43	-0.56	-0.48	-0.56
EPS Actual	-0.44	-0.48	-0.56	-0.59
Revenue Estimate	36.97M	39.08M	39.09M	41.12M
Revenue Actual	34.25M	35.97M	37.92M	36.82M

To track all earnings releases for Clovis Oncology visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.